- Home
- Equipment
- asia middle east
- precision target medicine
Show results for
Refine by
Precision Target Medicine Equipment Supplied In Asia Middle East
5 equipment items found
Manufactured by:Shenzhen Emperor Electronic Technology Co., Ltd. based inShenzhen, CHINA
For ten years, we insist on self-innovation to the end, and 13 years of technological precipitation have achieved the leap from digital black and white to digital color Doppler, creating the G series of basic medical and health applications. The G70 flagship machine gathers professional clinical strength and is born for precision medicine, providing high-quality images, advanced functions, and ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Celemics’ Oncorisk Panel is specifically designed to analyze hereditary cancer associated genes. The OncoRisk Panel targets 31 well-known oncogenes, leading to a reduction of totalsequencing cost compared to whole genome sequencing or whole exome sequencing. Additionally, if the gene of interest does not exist on the panel, it can be added separatelythrough our gene add-on service. This ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:CatchGene Co., Ltd based inNew Taipei City, TAIWAN
Everyone has Circulating cell-free DNA in our circulating system. In times past, people thought Circulating cell-free DNA were “junk” or just for recycling. But in the past two decades, scientists realized that not only normal cells but also cancer cells, embryo or even transplant organs will release their DNA into blood stream. Therefore, how to capture those very rare and small ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 and older is projected to reach nearly 2.1 billion by 2050, versus 962 million in 2017.1 This means that the number of patients in all fields will be ...